Home›People›Zhiping Weng
ZW

Zhiping Weng

Director at Rgenta Therapeutics.

Director
Updated Nov 13, 2026·Latest SEC filing Nov 3, 2026·Suggest an edit

About Zhiping Weng

Zhiping Weng is a director at Rgenta Therapeutics.

Zhiping Weng first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Zhiping Weng in the role, so the role may have started earlier or lasted longer.

Rgenta Therapeutics, Inc.
Director
2020 – 2026 · Woburn, MA
The company develops oral small-molecule drugs that target RNA to treat cancer and neurological diseases that current medicines cannot reach.

Key Colleagues at Startups

The people Zhiping Weng works with at each company, as listed on that company's latest Form D.

Rgenta Therapeutics, Inc. · Form D, Nov 3, 2026
HX
Hualin Xi
Co-founder and CEO, director
YF
Yichao Fan
Director
SZ
Sean Zhang
Director and promoter
CK
Cillian King
Director and promoter
JK
Travis Wager
Travis Wager
Co-founder, President and CSO
Jeff Guckert
Jeff Guckert
Director of Finance

Sources

  1. SECRgenta Therapeutics, Inc. Form D, filed Nov 3, 2026